Tested Applications
| Positive WB detected in | HeLa cells, PC-3 cells, DU 145 cells, mouse brain tissue, mouse stomach tissue |
| Positive IHC detected in | human prostate cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:4000 |
| Immunohistochemistry (IHC) | IHC : 1:400-1:1600 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
28203-1-AP targets SPOCK1 in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag28213 Product name: Recombinant human SPOCK1 protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 97-236 aa of BC030691 Sequence: CVTQDYQTALCVSRKHLLPRQKKGNVAQKHWVGPSNLVKCKPCPVAQSAMVCGSDGHSYTSKCKLEFHACSTGKSLATLCDGPCPCLPEPEPPKHKAERSACTDKELRNLASRLKDWFGALHEDANRVIKPTSSNTAQGR Predict reactive species |
| Full Name | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 |
| Calculated Molecular Weight | 439 aa, 49 kDa |
| Observed Molecular Weight | 49 kDa |
| GenBank Accession Number | BC030691 |
| Gene Symbol | SPOCK1 |
| Gene ID (NCBI) | 6695 |
| RRID | AB_3086036 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q08629 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for SPOCK1 antibody 28203-1-AP | Download protocol |
| WB protocol for SPOCK1 antibody 28203-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
SPOCK1 Polyclonal antibody (28203-1-AP) has 4 total citations. They appear in Int Immunopharmacol, BMC Cancer, Heliyon, and Cancer Cell Int. The research fields span oncology, focusing on chemoresistance genes in esophageal squamous cell carcinoma and cervical cancer, MARCO+ macrophage and SPOCK1+ fibroblast co-localization in colorectal cancer, extrachromosomal circular DNA-related SPOCK1 in prostate cancer, and an eight-gene prognostic signature in lung adenocarcinoma. Applications cited include IHC, IF, and WB.
| Species | Application | Title |
|---|---|---|
Int Immunopharmacol Shared chemoresistance genes in ESCC and cervical Cancer: Insights from pharmacogenomics and Mendelian randomization | ||
BMC Cancer The co-location of MARCO + macrophages and SPOCK1 + fibroblasts contributes to the poor prognosis and undesirable immunotherapy response in colorectal cancer. | ||
Heliyon Extrachromosomal circular DNA-related SPOCK1 contributes to development and enzalutamide resistance of prostate cancer by regulating epithelial mesenchymal transition | ||
Cancer Cell Int Single-cell-marker-based subtyping and multi-level analyses uncover the prognostic effects, dysregulations and therapeutic indicative potential of an eight-gene signature in lung adenocarcinoma. |







